25,210.81
+318.15
(+1.28%)
24,885
-325
(-1.29%)
低水326
8,352.67
+101.60
(+1.23%)
4,728.00
+10.76
(+0.228%)
14,123.31
+61.87
(+0.440%)
65,085.2500
-1,029.2500
(-1.557%)
22/01/2025 11:26
大行報告 | 蔚小理、藥明系、電訊股、比亞迪及領展最新評級/目標價,一表盡掌握
.高盛點評蔚小理,降理想(02015)、蔚來(09866)目標卻升小鵬(09868)目標
.高盛調升藥明系目標價,其中藥明康德(02359)目標由58元升至62.4元
.大摩看好中資電訊股,皆維持超配評級



1069,,新聞,專題透視,reports